ArticleBlood advances2025

Phase 1 study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult patients with B-ALL.

Jordan Gauthier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.